ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream

RxCUI: 2570752
RxNorm name: ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
Display name: ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
Full name: ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
OPZELURA	RUXOLITINIB	Incyte Corporation	24da5509-6631-4795-9d42-273faecd08e7	2026-06-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2570752

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
24da5509-6631-4795-9d42-273faecd08e7	ruxolitinib 15 MG (as ruxolitinib phosphate 19.8 MG) per 1 GM Topical Cream	SY	13	These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011	20251111
24da5509-6631-4795-9d42-273faecd08e7	ruxolitinib 15 MG/ML Topical Cream	PSN	13	These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011	20251111
24da5509-6631-4795-9d42-273faecd08e7	ruxolitinib 1.5 % Topical Cream	SY	13	These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011	20251111
24da5509-6631-4795-9d42-273faecd08e7	ruxolitinib 15 MG/ML Topical Cream	SCD	13	These highlights do not include all the information needed to use OPZELURA cream safely and effectively. See full prescribing information for OPZELURA cream. OPZELURA ® (ruxolitinib) cream, for topical use Initial U.S. Approval: 2011	20251111